Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-N6747 |
Brand: | MCE |
CAS: | 154589-96-5 |
MDL | - |
---|---|
Molecular Weight | 584.62 |
Molecular Formula | C35H28N4O5 |
SMILES | C[C@@]([C@@H]1OC)(O[C@](N2C3=CC=CC=C43)([H])C[C@H]1N(C)C(C5=CC=CC=C5)=O)N6C(C2=C4C(C7=O)=C8C(N7)=O)=C8C9=C6C=CC=C9 |
Stauprimide is a staurosporine analog that promotes embryonic stem cell (ESC) differentiation. Stauprimide is a non-broad spectrum inhibitor that binds to the MYC transcription factor NME2 and blocks its nuclear localization in ESCs, which results in down-regulation of MYC transcription [1] .
Stauprimide (10 μM; 6 hours) suppresses MYC transcription in the majority of cell lines tested with an EC
50
range of 30 nM-8 μM, and decreases MYC levels between 15% to over 90%
[1]
.
Stauprimide (2-8 μM; 24-72 hours) down-regulates MYC leads to the inhibition of cell proliferation in vitro with an IC
50
of 780 nM in RXF 393 cells
[1]
.
Stauprimide (5 μM; 3 hours) suppresses MYC Transcription by decreasing NME2 Nuclear Translocation
[1]
.
Stauprimide (4-10 μM; 6 hours) acts with different EC
50
s and with different degrees of maximal MYC mRNA down-regulation in different cell lines
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay [1]
Cell Line: | Renal cancer cell line RXF 393 cells |
Concentration: | 2 μM, 4 μM, 8 μM |
Incubation Time: | 24 hours, 48 hours, 72 hours |
Result: | Inhibited cell proliferation at concentrations of 2-8 μM. |
Western Blot Analysis [1]
Cell Line: | Renal cancer cell line RXF 393 cells and CAKI-1 cells |
Concentration: | 5 μM |
Incubation Time: | 3 hours |
Result: | Decreased nuclear localized NME2. |
RT-PCR [1]
Cell Line: | CA46 cells; Ramos cells; RXF393 cells; TK10 cells; KG1A cells; CAKI-1 cells |
Concentration: | 4μM, 6μM, 8μM, 10μM |
Incubation Time: | 6 hours |
Result: | Suppressed MYC transcription in KG1A cells with an EC 50 of 400±50 nM and a suppression of 90%; CA46 cells were resistant to stauprimide. |
Stauprimide (oral administration; 50 mg/kg; once daily; 30 days, 55 days) blocks tumor growth, reduces MYC protein levels in xenograft mouse with RXF 393 or CAKI-1 cells and inhibits MYC transcription in the RXF 393 tumor [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Xenograft tumor models with RXF 393 and CAKI-1 cells in NOD/SCID mice [1] |
Dosage: | 50 mg/kg |
Administration: | Oral administration; 50 mg/kg; once daily; 30 days, 55 days |
Result: | Blocked tumor growth in mice injected with either RXF 393 or CAKI-1 cells during the dosing periods. |
Solid
Room temperature in continental US; may vary elsewhere.
-20°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.